Erin Weeda to Hospitalization
This is a "connection" page, showing publications Erin Weeda has written about Hospitalization.
Connection Strength
1.458
-
Hospital admissions and emergency department visits among kidney transplant recipients. Clin Transplant. 2019 05; 33(5):e13522.
Score: 0.419
-
Saddle pulmonary embolism and in-hospital mortality in patients with cancer. Int J Clin Oncol. 2019 Jun; 24(6):727-730.
Score: 0.415
-
Association Between Potentially Inappropriate Medications and Hospital Encounters Among Older Adults: A Meta-Analysis. Drugs Aging. 2020 07; 37(7):529-537.
Score: 0.114
-
Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort study. Transpl Int. 2020 04; 33(4):414-422.
Score: 0.111
-
Agreement between coding schemas used to identify bleeding-related hospitalizations in claims analyses of nonvalvular atrial fibrillation patients. Clin Cardiol. 2018 Jan; 41(1):119-125.
Score: 0.096
-
Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarin. Intern Emerg Med. 2017 Apr; 12(3):311-318.
Score: 0.088
-
Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115.
Score: 0.088
-
Association between weekend admission for atrial fibrillation or flutter and in-hospital mortality, procedure utilization, length-of-stay and treatment costs. Int J Cardiol. 2016 Jan 01; 202:427-9.
Score: 0.082
-
External validation of a multivariable claims-based rule for predicting in-hospital mortality and 30-day post-pulmonary embolism complications. BMC Health Serv Res. 2016 10 22; 16(1):610.
Score: 0.022
-
Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism? Clin Appl Thromb Hemost. 2017 Oct; 23(7):830-837.
Score: 0.022